HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.

13th Edition of International Conference on Neurology and Brain Disorders

October 19-21, 2026

October 19 -21, 2026 | Boston, Massachusetts, USA
INBC 2026

From open-loop to precision psychiatry: Integrating brain state, temporal precision, and behavioral context in neuromodulation

Speaker at Brain Disorders Conference - Daniel Lam
Rutgers Robert Wood Johnson Medical School, United States
Title : From open-loop to precision psychiatry: Integrating brain state, temporal precision, and behavioral context in neuromodulation

Abstract:

Background: Transcranial magnetic stimulation (TMS) is an established intervention for several psychiatric disorders, including major depressive disorder; however, clinical response remains heterogeneous. Conventional neuromodulation protocols typically rely on fixed stimulation parameters delivered independently of ongoing neural activity or behavioral context. Converging evidence indicates that neuromodulation effects are fundamentally state-dependent, influenced by intrinsic oscillatory dynamics, baseline cortical excitability, and functional network engagement at the time of stimulation. These findings motivate a shift away from static, open-loop paradigms toward adaptive frameworks integrating temporal precision, brain-state monitoring, and contextual modulation.
Objective: To synthesize human evidence supporting state-dependent neuromodulation and to evaluate emerging strategies that integrate temporal precision, neurophysiological monitoring, and behavioral context to enhance therapeutic efficacy in psychiatric disorders.
Methods: A structured narrative literature review was conducted across PubMed, Scopus, and Web of Science, covering publications from 2005 to 2025. Search terms included combinations of transcranial magnetic stimulation, state-dependent stimulation, EEG-guided TMS, phase-locked stimulation, closed-loop neuromodulation, concurrent therapy, and focused ultrasound. Inclusion criteria comprised human studies involving non-invasive neuromodulation that explicitly examined brain state, oscillatory phase, or behavioral context at the time of stimulation and were relevant to psychiatric or affective disorders. Approximately 50 peer-reviewed articles met inclusion criteria and were thematically categorized into four domains: (1) state-dependent effects of TMS, (2) EEG-informed and phase-locked stimulation paradigms, (3) neuromodulation delivered concurrently with cognitive or behavioral interventions, and (4) emerging modalities supporting adaptive neuromodulation.
Results: Across studies, neuromodulation effects consistently depended on baseline cortical excitability, oscillatory phase, and functional network engagement. EEG-guided and phase-locked TMS paradigms demonstrated enhanced modulation of cortical excitability and reduced response variability compared with non-synchronized stimulation. Concurrent behavioral engagement, including psychotherapy or task-based activation during stimulation, appeared to shape neural state in ways that may amplify plasticity and therapeutic response. Emerging modalities such as transcranial focused ultrasound offer increased spatial precision and access to deeper neural targets, positioning them as complementary tools for future closed-loop, state-informed neuromodulation frameworks.
Conclusion: Neuromodulation efficacy may depend less on stimulation intensity alone and more on when and in what context stimulation is delivered. Integrating temporal precision, brain-state monitoring, and behavioral context represents a promising direction for advancing neuromodulation toward adaptive, personalized psychiatric interventions.

Biography:

Daniel Lam is a medical student with academic interests spanning psychiatry, neuromodulation, and emerging mental health technologies. At the core of his work is a focus on the individual patient experience, integrating internal insight, psychodynamic and psychotherapeutic frameworks with modern psychiatric interventions. His research interests include interventional psychiatry, treatment-resistant mood and psychotic disorders, state-dependent neuromodulation, and novel pharmacologic and psychedelic-assisted treatments. He is particularly interested in how combining psychotherapy with neuromodulation and other emerging technologies may unlock more precise, personalized, and clinically meaningful psychiatric care.

Watsapp